Table 2.

Duration and outcomes with T2DM and COVID-19 treated with DPP-4i and without DPP-4i

	On DPP-4i	Not on DPP-4i	Total patients	p
Duration
The time between first symptom and hospitalization, median (days)	4.19±2.84	4.74±3.87	4.61±3.64	0.483
Hospitalization time, median (days)	10.96±9.16	12.22±9.10	11.91±9.11	0.384
Outcome (%)
High-flow nasal cannula	1.9	5.5	4.6	0.457
Mechanic ventilation	11.3	15.2	14.3	0.478
Death	5.7	12.8	11.1	0.208
3-month post-discharge mortality	6	3.49	4.14	0.383

Total means, using DPP-4 inh and not using DPP-4 inh. T2DM: Type 2 diabetes mellitus; DPP-4i: Dipeptidyl peptidase inhibitor.